Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

三代显 - NMPA Drug Approval Details

Approvals/NMPA/Iobitridol Injection

Approved

化学药品

Iobitridol Injection

LIEBEL-FLARSHEIM COMPANY LLC🇨🇳 National Medical Products Administration

Approval Date: Jun 8, 2021
Approval ID: 887B5qPJg8d
Company: LIEBEL-FLARSHEIM COMPANY LLC
Type: 化学药品

Approval Details

Approval Id: 887B5qPJg8d
Approval Number: 国药准字HJ20160376
Generic Name: 碘比醇注射液
Generic Name En: Iobitridol Injection
Trade Name: 三代显
Brand Name: 三代显
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 100ml:30g (I)
Reg Date: 2021-06-08
Expired Date: 2026-06-07
Company Name: LIEBEL-FLARSHEIM COMPANY LLC
Production Company Name: LIEBEL-FLARSHEIM COMPANY LLC
Company Detail Path: /organization/liebel-flarsheim-company-llc
Production Company Detail Path: /organization/liebel-flarsheim-company-llc

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 8, 2021

Approval ID

887B5qPJg8d

Type

化学药品

Back to NMPA Approvals